Characteristics of current benzodiazepine users as indicators of differences in physical and mental health

Pharmacy World and Science

Volumn 22, Issue 3, 2000, Pages 96-101

  van Hulten, Rolf ^a   Teeuw, K Bart ^a   Leufkens, Hubert G ^a   Bakker, Arnold B ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Benzodiazepines; Health Status; MCS; PCS; RAND 36

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONSULTATION; DEPRESSION; DRUG EXPOSURE; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH CARE; MUSCLE RELAXATION; PATIENT CODING; PRESCRIPTION; QUALITY OF LIFE; RISK FACTOR; STRESS; WIDOW;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-ANXIETY AGENTS, BENZODIAZEPINE; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HEALTH STATUS INDICATORS; HUMAN; MALE; MENTAL HEALTH; MIDDLE AGE; NETHERLANDS; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK ASSESSMENT;

EID: 0033834494     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008749220107     Document Type: Article

References (32)

1. Benzodiazepines: Use, abuse, and consequences
2. Hypnotics. Their place in therapeutics
3. Use of benzodiazepines in anxiety disorders
4. Prevalence and correlates of the long-term regular use of anxiolytics
5. Controlled comparison of the characteristics of long-term benzodiazepine users in general practice
6. Health of long term benzodiazepine users
7. Benzodiazepine prescribing in general practice: Dispelling some myths
8. Clinical aspects of chronic use of alprazolam and lorazepam
9. Characteristics of long term benzodiazepine users in general practice
10. Use of benzodiazepines in the community
11. Ill-health and social predictors of psychotropic drug prescription in general practice
12. Information on drug use in the elderly: A comparison of pharmacy, general practitioner and patient data
13. Concomitant drug use among patients on cardiac glycosides
14. New epidemiologic findings about insomnia and its treatment
15. Automated record linkage and other approaches to pharmacoepidemiology in the Netherlands
16. Patient targeting and outcomes
17. Variability in patterns of drug usage
18. Comparison of methods for the scoring and statistical analysis of sf-36 health profile and summary measures: Summary of results from the medical outcome study
19. The MOS 36-item short-form health survey (SF-36), I: Conceptual framework and item selection
20. The RAND 36-Item Health Survey 1.0
21. The defined daily dose per 100 beddays as a unit of comparison and a parameter for studying antimicrobial drug use in a university hospital
22. A chronic disease score from automated pharmacy data
23. Replicating the chronic disease score (CDS) from automated pharmacy data
24. Benzodiazepine pathways in the chronically III
25. Benzodiazepine anti-anxiety agents: Prevalence and correlates of use in a southern community
26. Risk factors in the use of benzodiazepines
27. Clinical variables in pharmacoepidemiology
28. The comorbidity of anxiety and depression